Question
Is Synapsa (Bacopa CDRI-08) legit?
In context of Synapsa (Bacopa CDRI-08)·Mixed evidence66/100
In our editorial model, Synapsa (Bacopa CDRI-08) maps to a Mixed evidence verdict at 66/100 overall (evidence 62/100, safety 74/100, hype gap 52/100). Attention / working memory; Branded. Typical label framing: 300-320 mg in some studies
Full ingredient file
This page is a short answer. Mechanisms, dosing notes, sources, and the rest of the verdict live on the hub for Synapsa (Bacopa CDRI-08).
Open Synapsa (Bacopa CDRI-08) verdictOther questions on Synapsa (Bacopa CDRI-08)
A few more focused pages for the same ingredient (we keep lists short on purpose).